Lysine acetylation is a reversible posttranslational modifcation, an epigenetic phenomenon, referred to as transfer of an acetyl group from acetyl CoA to lysine ε- amino group of targeted protein, which is modulated by acetyltransferases (histone/ lysine (K) acetyltransferases, HATs/KATs) and deacetylases (histone/lysine (K) deacetylases, HDACs/KDACs). Lysine acetylation regulates various metabolic processes, such as fatty acid oxidation, Krebs cycle, oxidative phosphorylation, angiogenesis and so on. Thus disorders of lysine acetylation may be correlated with obesity, diabetes and cardiovascular disease, which are termed as the metabolic complication. With accumulating studies on proteomic acetylation, lysine acetylation also involves in cell immune status and degenerative diseases, for example, Alzheimer’s disease and Huntington’s disease. This review primarily summarizes the current studies of lysine acetylation in metabolism modulation and in metabolism-related diseases, such as cardiovascular disease and fat metabolism disorder.
Choudhary, C., Kumar, C., Gnad, F., et al. (2009) Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions. Science, 325, 834-840. http://dx.doi.org/10.1126/science.1175371
Zhao, S.M., Xu, W., Jiang, W.Q., et al. (2010) Regulation of Cellular Metabolism by Protein Lysine Acetylation. Science, 327, 1000-1004. http://dx.doi.org/10.1126/science.1179689
Wang, Q.J., Zhang, Y.K., Yang, C., et al. (2010) Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux. Science, 327, 1004-1007. http://dx.doi.org/10.1126/science.1179687
Panchal, S.K. and Brown, L. (2011) Rodent Models for Metabolic Syndrome Research. Journal of Biomedicine and Biotechnology, 2011, Article ID: 351982. http://dx.doi.org/10.1155/2011/351982
Zhang, K.L., Schrag, M., Crofton, A., Trivedi, R., Vinters, H. and Kirsch, W. (2012) Targeted Proteomics for Quantification of Histone Acetylation in Alzheimer’s Disease. Protemics, 12, 1261-1268. http://dx.doi.org/10.1002/pmic.201200010
Irwin, D.J., Cohen, T.J., Grossman, M., et al. (2012) Acetylated Tau, a Novel Pathological Signature in Alzheimer’s Disease and Other Tauopathy. Brain, 135, 807-818. http://dx.doi.org/10.1093/brain/aws013
Cohen, T.J., Friedmann, D., Hwang, A.W., Marmorstein, R. and Lee, V.M.Y. (2013) The Microtubule-Associated Tau Protein Has Intrinsic Acetyltransferase Activity. Nature Structural & Molecular Biology, 20, 756-762. http://dx.doi.org/10.1038/nsmb.2555
Yang, X.-J. and Seto, E. (2008) The Rpd3/Hda1 Family of Lysine Deacetylases: From Bacteria and Yeast to Mice and Men. Nature Reviews Molecular Cell Biology, 9, 206-218. http://dx.doi.org/10.1038/nrm2346
Kjaergaard, M., Nørholm, A.B., Hendus-Altenburger, R., Pedersen, S.F., Poulsen, F.M. and Kragelund, B.B. (2010) Temperature-Dependent Structural Changes in Intrinsically Disordered Proteins: Formation of α-Helices or Loss of Polyproline II? Protein Science, 19, 1555-1564. http://dx.doi.org/10.1002/pro.435
Lonard, D.M. and O’Malley, B.W. (2013) Nuclear Receptor Coregulators: Modulators of Pathology and Therapeutic Targets. Nature Reviews Endocrinology, 8, 598-604. http://dx.doi.org/10.1038/nrendo.2012.100
Wang, S.W., Jiang, B.W., Zhang, T.F., et al. (2015) Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLoS Biology, 13. e1002243. http://dx.doi.org/10.1371/journal.pbio.1002243
Gainey, M.A., Tatavarty, V., Nahmani, M., Lin, H. and Turrigiano, G.G. (2015) Activity-Dependent Synaptic GRIP1 Accumulation Drives Synaptic Scaling up in Response to Action Potential Blockade. Proceedings of the National Academy of Sciences of the United States of America, 112, E3590-E3599. http://dx.doi.org/10.1073/pnas.1510754112
Schwer, B., Bunkernborg, J., Verdin, R.O., Andersen, J.S. and Verdin, E. (2006) Reversible Lysine Acetylation Controls the Activity of the Mitochondrial Enzyme Acetyl-COA Synthetase 2. Proceedings of the National Academy of Sciences of the United States of America, 1003, 10224-10229. http://dx.doi.org/10.1073/pnas.0603968103
Bharathi, S.S., Zhang, Y., Mohsen, A.W., et al. (2013) SIRT3 Regulates Long-Chain Acetyl-CoA Dehydrogenase by Deacetylating Conserved Lysines near the Active Site. The Journal of Biological Chemistry, 288, 33837-33847. http://dx.doi.org/10.1074/jbc.M113.510354
Someya, S., Yu, W., Hallows, W.C., et al. (2010) Sirts Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction. Cell, 143, 802-812. http://dx.doi.org/10.1016/j.cell.2010.10.002
Zhang, Y., Bharathi, S.S., Rardin, M.J., et al. (2015) SIRT3 and SIRT5 Regulates the Enzyme Activity and Cardiolipin Binding of Very Long-Chain Acyl-CoA Dehydrogenase. PLoS ONE, 10, e0122297. http://dx.doi.org/10.1371/journal.pone.0122297
Fernandes, J., Weddle, A., Kinter, C.S., et al. (2015) Lysine Acetylation Activates Mitochondrial Aconitase in the Heart. Biochemistry, 54, 4008-4018. http://dx.doi.org/10.1021/acs.biochem.5b00375
Yang, Y., Cimen, H. and Hanetal, M.J. (2010) NAD-Dependent Deacetylase SIRT3 Regulates Mitochondrial Protein Synthesis by Deacetylation of the Ribosomal Protein MRPL10. Journal of Biological Chemistry, 285, 7417-7429. http://dx.doi.org/10.1074/jbc.M109.053421
Cimen, H., Han, M.J., Yang, Y., et al. (2010) Regulation of Succinate Dehydrogenase Activity by SIRT3 in Mammalian Mitochondria. Biochemistry, 49, 304-311. http://dx.doi.org/10.1021/bi901627u
Wei, L., Zhou, Y., Dai, Q., et al. (2013) Oroxylin A Induces Dissociation of Hexokinase II from the Mitochondria and Inhibits Glycolysis by SIRT3-Mediated Deacetylation of Cyclophilin D in Breast Carcinoma. Cell Death & Disease, 4, e601. http://dx.doi.org/10.1038/cddis.2013.131
Lagouge, M., Argmann, C., Gerhart-Hines, Z., et al. (2006) Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α. Cell, 127, 1109-1122. http://dx.doi.org/10.1016/j.cell.2006.11.013
Hallows, W.C., Lee, S. and Denu, J.M. (2006) Sirtuins Deacetylate and Activate Mammalian Acetyl-CoA Synthetases. Proceedings of the National Academy of Sciences of the United States of America, 103, 10230-10235. http://dx.doi.org/10.1073/pnas.0604392103
Mostoslavsky, R., Chua, K.F., Lombard, D.B., et al. (2006) Genomic Instability and Aging-Like Phenotype in the Absence of Mammlian SIRT6. Cell, 124, 315-329. http://dx.doi.org/10.1016/j.cell.2005.11.044
Huang, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and Integrative Analysis of Large Gene Lists Using DAVID Bioinformatics Resources. Nature Protocols, 4, 44-57. http://dx.doi.org/10.1038/nprot.2008.211
Narayan, N., Lee, I.H., Borenstein, R., et al. (2012) The NAD-Dependent Deacetylase SIRT2 Is Required for Programmed Necrosis. Nature, 492, 199-204. http://dx.doi.org/10.1038/nature11700
Krishnan, J., Danzer, C., Simka, T., et al. (2012) Dietary Obesity-Associated Hif1Alpha Activation in Adipocytes Restricts Fatty Acid Oxidation and Energy Expenditure via Suppression of the Sirt2-NAD+ System. Genes & Development, 26, 259-270. http://dx.doi.org/10.1101/gad.180406.111
Jing, E., Gesta, S. and Kahn, C.R. (2007) SIRT2 Regulates Adipocyte Differentiation through FoxO1 Acetylation/Deacetylation. Cell Metabolism, 6, 105-114. http://dx.doi.org/10.1016/j.cmet.2007.07.003
Wang, F. and Tong, Q. (2009) SIRT2 Suppresses Adipocyte Differentiation by Deacetylating FOXO1 and Enhancing FOXO1’s Repressive Interaction with PPARgamma. Molecular Biology of the Cell, 20, 801-808. http://dx.doi.org/10.1091/mbc.E08-06-0647
Qiang, L., Wang, L., Kon, N., et al. (2012) Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ. Cell, 150, 620-632. http://dx.doi.org/10.1016/j.cell.2012.06.027
Jiang, S., Wang, W., Miner, J., et al. (2012) Cross Regulation of Sirtuin 1, AMPK and PPARγ in Conjugated Linoleic Acid Treated Adipocytes. PLoS ONE, 7, e48874. http://dx.doi.org/10.1371/journal.pone.0048874
Jin, Q., Zhang, F., Yan, T., et al. (2010) C/EBPα Regulates SIRT1 Espression during Adipogenesis. Cell Research, 20, 470-479. http://dx.doi.org/10.1038/cr.2010.24
Qiao, L. and Shao, J. (2006) SIRT1 Regulates Adiponectin Gene Expression through FoxO1-C/Enhancer-Binding Protein Alpha Transcriptional Complex. Journal of Biological Chemistry, 281, 39915-39924. http://dx.doi.org/10.1074/jbc.M607215200
Khan, S.A., Ali, A., Khan, S.A., et al. (2014) Unraveling the Complex Relationship Triad between Lipids, Obesity, and Inflammation. Mediators of Inflammation, 2014, Article ID: 502749. http://dx.doi.org/10.1155/2014/502749
Iyer, A., Fairlie, D.P., Prins, J.B., et al. (2010) Inflammatory Lipid Mediators in Adipocyte Function and Obesity. Nature Reviews Endocrinology, 6, 71-82. http://dx.doi.org/10.1038/nrendo.2009.264
Catalioto, R.M., Maggi, C.A. and Giuliani, S. (2009) Chemically Distinct HDAC Inhibitors Prevent Adipose Conversion of Subcutaneous Human White Preadipocytes at an Early Stages of the Differentiation Program. Experimental Cell Research, 315, 3267-3280. http://dx.doi.org/10.1016/j.yexcr.2009.09.012
Haberland, M., Carrer, M., Mokalled, M.H., et al. (2010) Redundant Control of Adipogenesis by Histone Deacetylases 1 and 2. Journal of Biological Chemistry, 285, 14663-14670. http://dx.doi.org/10.1074/jbc.M109.081679
Yoo, E.J., Chung, J.J., Choe, S.S., et al. (2006) Down-Regulation of Histone Deacetylases Stimulates Adipocyte Differentiation. Journal of Biological Chemistry, 281, 6608-6615. http://dx.doi.org/10.1074/jbc.M508982200
Sano, M., Minamino, T., Toko, H., et al. (2007) p53-Induced Inhibition of Hif-1 Causes Cardiac Dysfunction during Pressure Overload. Nature, 446, 444-448. http://dx.doi.org/10.1038/nature05602
Potente, M., Ghaeni, L., Baldessari, D., et al. (2007) SIRT1 Controls Endothelial Angiogenic Functions during Vascular Growth. Genes & Development, 21, 2644-2658. http://dx.doi.org/10.1101/gad.435107
Heather, L.C., Cole, M.A., Tan, J.J., et al. (2012) Metabolic Adaptation to Chronic Hypoxia in Cardiac Mitochondria. Basic Research in Cardiology, 107, 268. http://dx.doi.org/10.1007/s00395-012-0268-2
Fukuda, S., Kaga, S., Zhan, L., et al. (2006) Resveratrol Ameliorates Myocardial Damage by Inducing Vascular Endothelial Growth Factor-Angiogenesis and Tyrosine Kinase Receptor Flk-1. Cell Biochemistry and Biophysics, 44, 43-49. http://dx.doi.org/10.1385/CBB:44:1:043
Chen, R., Dioum, E.M., Hogg, R.T., et al. (2011) Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-Inducible Factor-Dependent Manner. Journal of Biological Chemistry, 286, 13869-13878. http://dx.doi.org/10.1074/jbc.M110.175414
Benigni, A., Corna, D., Zoja, C., et al. (2009) Disruption of the Ang II Type 1 Receptor Promotes Longevity in Mice. Journal of Clinical Investigation, 119, 524-530. http://dx.doi.org/10.1172/JCI36703
Hsu, C.P., Oka, S., Shao, D., et al. (2009) Nicotinamide Phosphoribosyltransferase Regulates Cell Survival through NAD+ Synthesis in Cardiac Myocytes. Circulation Research, 105, 481-491. http://dx.doi.org/10.1161/CIRCRESAHA.109.203703
Pillai, V.B., Sundaresan, N.R., Kim, G., et al. (2010) Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-Activated Kinase Pathway. Journal of Biological Chemistry, 285, 3133-3144. http://dx.doi.org/10.1074/jbc.M109.077271
Lombard, D.B., Alt, F.W., Cheng, H.L., et al. (2007) Mammalian Sir2 Homolog SIRG3 Regulates Global Mitochondrial Lysine Acetylation. Molecular and Cellular Biology, 27, 8807- 8814. http://dx.doi.org/10.1128/MCB.01636-07
Sun, Y., Jiang, X., Chen, S., et al. (2006) Inhibition of Histone Acetyltransferase Activity by Anacardic Acid Sensitizes Tumor Cells to Ionizing Radiation. FEBS Letters, 580, 4353- 4356. http://dx.doi.org/10.1016/j.febslet.2006.06.092
Stimson, L., Rowlands, M.G., Newbatt, Y.M., et al. (2005) Isothiazolones as Inhibitors of PCAF and p300 Histone Acetyltransferase Activity. Molecular Cancer Therapeutics, 4, 1521-1532. http://dx.doi.org/10.1158/1535-7163.MCT-05-0135
Wapenaar, H. and Dekker, F.J. (2016) Histone Acetyltransferases: Challenges in Targeting Bi-Substrate Enzymes. Clinical Epigenetics, 8, 59. http://dx.doi.org/10.1186/s13148-016-0225-2
Filippakopoulos, P., Qi, J., Picaud, S., et al. (2010) Seletive Inhibition of BET Bromodomains. Nature, 468, 1067-1073. http://dx.doi.org/10.1038/nature09504
Bertrand, P. (2010) Inside HDAC with HDAC Inhibitors. European Journal of Medicinal Chemistry, 4, 2095-2116. http://dx.doi.org/10.1016/j.ejmech.2010.02.030
Iyer, A., Fenning, A., Lim, J., et al. (2010) Antifbrotic Activity of an Inhibitor of Histone Deacetylases in DOCA-Salt Hypertensive Rats. British Journal of Clinical Pharmacology, 159, 1408-1417. http://dx.doi.org/10.1111/j.1476-5381.2010.00637.x
Adamopoulou, E. and Naumann, U. (2013) HDAC Inhibitors and Their Potential Applications to Glioblastoma Therapy. Oncoimmunology, 2, Article ID: e25219. http://dx.doi.org/10.4161/onci.25219
Chan, V., Fenning, A., Iyer, A., Hoey, A. and Brown, L. (2011) Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats. Current Pharmaceutical Biotechnology, 12, 429-436. http://dx.doi.org/10.2174/138920111794480552